Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Evid Based Med
Asıl Yazarlar: Alper, Brian Scott, Foster, Gary, Thabane, Lehana, Rae-Grant, Alex, Malone-Moses, Meghan, Manheimer, Eric
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548536/
https://ncbi.nlm.nih.gov/pubmed/32430395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjebm-2020-111386
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller